education
|
UnregisterUser
|
IsNClickFreeLimitExceeded: True
|
NClickFreeLimit: 0
|
Download App
India
search
Sign in
Home
Find Drugs
Find Drug Company
Diseases
Medical News & Updates
Country
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Points
Download App
Country
India
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Sign in
Home
Find Drugs
Find Drug Company
Diseases
Medical News & Updates
CIMS home
Drugs
Info
CYRAMZA
CYRAMZA
Manufacturer:
Eli Lilly
Basic Prescribing Info
Contents
ramucirumab.
CIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG02 - ramucirumab ; Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.
Presentation/Packing
Form
CYRAMZA inj
Packing/Price
100 mg x 10ml (51,546 INR);500 mg x 50ml (257,532 INR)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Continue with Google
OR
Sign Up
Already a member?
Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Continue with Google
OR
Sign Up
Already a member?
Sign in
Sign Out
